Clinical notes| Volume 86, ISSUE 3, P594-595, March 2005

Severe trismus as a complication of cerebrovascular accident: A case report


      Kadyan V, Clairmont AC, Engle M, Colachis SC. Severe trismus as a complication of cerebrovascular accident: a case report.
      Spastic hypertonia is a common sequelae after a cerebrovascular accident (CVA) and is a component of an upper motoneuron lesion. Management of spastic hypertonia may involve the use of centrally acting agents, peripheral blockade, and ablative therapies. We report a case of spastic hypertonia leading to severe trismus after CVA that was successfully treated with botulinum toxin type A. Severe trismus is a potentially life-threatening condition that may lead to permanent functional impairment if not promptly diagnosed and treated. Using electromyography for botulinum toxin muscle selection in this case appears to have helped decrease the dose of botulinum toxin given as well as minimize potential side effects.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Archives of Physical Medicine and Rehabilitation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Marien Jr, M.
        Trismus: causes, differential diagnosis, and treatment.
        Gen Dent. 1997; 45: 350-355
        • Tveteras K.
        • Kristensen S.
        The aetiology and pathogenesis of trismus.
        Clin Otolaryngol. 1986; 11: 383-387
        • Meythaler J.M.
        • Guin-Renfroe S.
        • Brunner R.C.
        • Hadley M.N.
        Intrathecal baclofen for spastic hypertonia from stroke.
        Stroke. 2001; 32: 2099-2109
        • Schwartz M.
        • Freund B.
        Treatment of temporomandibular disorders with botulinum toxin.
        Clin J Pain. 2002; 18: S198-S203
        • Sheean G.
        The pathophysiology of spasticity.
        Eur J Neurol. 2002; 9 (discussion 53–61): 3-9
        • Barnes M.P.
        • Johnson G.R.
        Upper motor neurone syndrome and spasticity: clinical management and neurophysiology.
        Cambridge Univ Pr, New York2001 (p ix, 317)
        • Spillane K.S.
        • Shelton J.E.
        • Hasty M.F.
        Stroke-induced trismus in a pediatric patient: long-term resolution with botulinum toxin A.
        Am J Phys Med Rehabil. 2003; 82: 485-488
        • Ivanhoe C.B.
        • Lai J.M.
        • Francisco G.E.
        Bruxism after brain injury: successful treatment with botulinum toxin-A.
        Arch Phys Med Rehabil. 1997; 78: 1272-1273
        • Tan E.K.
        • Jankovic J.
        Treating severe bruxism with botulinum toxin.
        J Am Dent Assoc. 2000; 131: 211-216
        • Winterholler M.G.
        • Heckmann J.G.
        • Hecht M.
        • Erbguth F.J.
        Recurrent trismus and stridor in an ALS patient: successful treatment with botulinum toxin.
        Neurology. 2002; 58: 502-503